Serum Vascular Endothelial Growth Factor VEGF and Interlukin-8 As a Novel Biomarkers For Early Detection of Ovarian Tumors

Authors

Maisaa G. Jumaa
Khalid A. Habib
Munther J. Hussein

Abstract

Epithelial ovarian cancer is the leading cause of cancer deaths from gynecological malignancies. Angiogenesis is considered essential for tumor growth and the development of metastases. VEGF and IL-8 are potent angiostimulatory molecules and their expression has been demonstrated in many solid tumors, including ovarian cancer.VEGF and IL-8 concentrations were measured by ELISA test (HumanVEGF,IL-8). Bioassay ELISA/ US Biological / USA).The median VEGF and IL-8 levels were significantly higher in the sera of ovarian cancer patients than in those with benign tumors and in healthy controls.Pretreatment VEGF and IL-8 serum levels might be regarded as an additional tool in the differentiation of ovarian tumors.

Keywords

cancer, VEGF, IL8, Serum

Article Type

Article

How to Cite this Article

Jumaa, Maisaa G.; Habib, Khalid A.; and Hussein, Munther J. (2015) "Serum Vascular Endothelial Growth Factor VEGF and Interlukin-8 As a Novel Biomarkers For Early Detection of Ovarian Tumors," Baghdad Science Journal: Vol. 12: Iss. 2, Article 9.
DOI: https://doi.org/10.21123/bsj.2015.12.2.293-300